Bioactive C-Glycosides from Bacterial Secondary Metabolism

Author(s): Philip G. Hultin

Journal Name: Current Topics in Medicinal Chemistry

Volume 5 , Issue 14 , 2005

Become EABM
Become Reviewer


C-Glycosides are commonly regarded as unusual structures, but they are far more prevalent among natural products than is imagined. This review discusses the C-glycosidic compounds produced by various bacteria, particularly the "biosynthetically talented" Streptomyces. The major structure types are presented, along with brief descriptions of the known biological and pharmacological properties of the compounds. Recent work has uncovered the genetic basis for the biosynthesis of several bacterial C-glycosides, and emphasis is placed on those cases where it has been possible to identify (at least provisionally) the C-glycosyltransferase in the pathway. Prospects for biosynthetic engineering, combinatorial biosynthesis, or glycorandomization in C-glycosidic natural products are briefly discussed.

Keywords: salmochelin, iroA gene, Baeyer-Villiger oxidation, Ravidomycin, gilvocarcins, DNA alkylating agents

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [1299 - 1331]
Pages: 33
DOI: 10.2174/156802605774643015
Price: $65

Article Metrics

PDF: 21